|Articles|June 1, 2017
Bracket Releases IRT Solution
Advertisement
Bracket, a clinical trial technology and specialty services provider, announced the release of CUBETM, a transformative interactive response technology (IRT) solution for the life sciences industry.
The solution leverages an iterative user acceptance build experience, which allows a UAT process that study teams can visualize during the kick off meeting. Features include:
Accelerate times for sponsors and improves efficiency for CROs
Leverages Bracket's RTSM platform, but streamlines deployment through automation
Rapid project lifecycle lets sponsors experience the system prior to requirements approval
Reduce lengthy turnaround times for enhancements and in-study changes
The solution leverages an iterative user acceptance build experience, which allows a UAT process that study teams can visualize during the kick off meeting. Features include:
Accelerate times for sponsors and improves efficiency for CROs
Leverages Bracket's RTSM platform, but streamlines deployment through automation
Rapid project lifecycle lets sponsors experience the system prior to requirements approval
Reduce lengthy turnaround times for enhancements and in-study changes
Read the full release here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
2
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
3
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
4
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
5